Pleural Tuberculosis in a Patient After COVID-19 Pneumonia

Year 2022, Volume: 5 Issue: 1, 101 - 103, 01.01.2022

Sevil Alkan , Emine Kübra Dindar Demiray , Mehmet Durgun , Özgür Paşa , Sinem Sefer

https://doi.org/10.19127/bshealthscience.944827

Abstract

During the coronavirus disease 2019 (COVID-19) pandemic, it was observed that the clinics of existing and undiagnosed tuberculosis (TB) patients were more severe, especially in low and middle-income countries where TB is endemic and there is a lack of healthcare. There is limited literature on whether the coexistence of TB and COVID 19 or the lung damage/immune state caused by COVID-19, or whether immunosuppressive therapies used during the treatment of COVID-19 whether it creates a predisposition to TB. In this case report, we aimed to present a 66-year-old female patient diagnosed as pleural tuberculosis after COVID-19 pneumonia and to examine the possible relationship between COVID-19 and TB.

Keywords

COVID 19, Pleural tuberculosis, Tuberculosis, Empyema

Project Number

yok

References

• AlKhateeb MH, Aziz A, Eltahir M, Elzouki A. 2020. Bilateral foot-drop secondary to axonal neuropathy in a tuberculosis patient with co-infection of COVID-19: A Case Report. Cureus, 12(11), e11734. https://doi.org/10.7759/cureus.11734.
• Khurana AK, Aggarwal D. 2020. The (in) significance of TB and COVID-19 co-infection. Eur Respir J, 56(2), 2002105. https://doi.org/10.1183/13993003.02105-2020.
• Motta I, Centis R, D'Ambrosio L, García-García JM, Goletti D, Gualano G, Lipani F, Palmieri F, Sánchez-Montalvá A, Pontali E, Sotgiu G, Spanevello A, Stochino C, Tabernero E, Tadolini M, van den Boom M, Villa S, Visca D, Migliori G.B. 2020. Tuberculosis, COVID-19 and migrants: Preliminary analysis of deaths occurring in 69 patients from two cohorts. Pulmonol, 26(4): 233–240.
• Mousquer GT, Peres A, Fiegenbaum M. 2021. Pathology of TB/COVID-19 Co-Infection: The phantom menace. Tuberculosis, 126: 102020.
• Tadolini M, Codecasa LR, García-García JM, Blanc FX, Borisov S, Alffenaar JW, Andréjak C, Bachez P, Bart PA, Belilovski E, Cardoso-Landivar J, Centis R, D'Ambrosio L, Luiza De Souza-Galvão M, Dominguez-Castellano A, Dourmane S, Jachym MF, Froissart A, Giacomet V, Goletti D, Grard S, Gualano G, Izadifar A, Le Du D, Royo MM, Mazza-Stalder J, Motta I, Ong CWM, Palmieri F, Rivière F, Rodrigo T, Silva DR, Sánchez-Montalvá A, Saporiti M, Scarpellini P, Schlemmer F, Spanevello A, Sumarokova E, Tabernero E, Tambyah PA, Tiberi S, Torre A, Visca D, Murguiondo MZ, Sotgiu G, Migliori GB. 2020. Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases. Eur Respir J, 56(1): 2001398.
• Togun T, Kampmann B, Stoker NG, Lipman M. 2020. Anticipating the impact of the COVID-19 pandemic on TB patients and TB control programmes. Ann Clin Microbiol Antimicrob, 19(1): 21.
• URL 1. https://covid19.saglik.gov.tr/ (access date: January 31, 2021).
• URL 2. https://www.who.int/emergencies/diseases/novel-coronavirus-2019 (access date: March 4, 2021).
• URL 3. https://hsgm.saglik.gov.tr/tr/tuberkuloz-istatistikler (access date: March 4, 2021).
• URL 4. Liu Y, Bi L, Chen Y, Wang Y, Fleming J, Yu Y, et al. Active or latent tuberculosis increases susceptibility to COVID-19 and disease severity. MedRxiv. [preprint]. https://www.medrxiv.org/content/10.1101/2020.03.10.20033795v1 (access date: March 4, 2021).
• Wingfield T, Cuevas LE, MacPherson P, Millington KA, Squire SB. 2020. Tackling two pandemics: a plea on World Tuberculosis Day. Lancet Respir Med, 8(6): 536-538.